In September 2023, FDA approved Exxua (gepirone), a new extendedrelease antidepressant. When Exxua comes to the market in early 2024, it will mark a new treatment option for the estimated 21 million Americans who are affected by major depressive disorder (MDD) each year.

Lauren Howell, PharmD

DHEA supplements are advertised as an antidote to aging. Products on store shelves also purport that DHEA supports immune balance, metabolism, sexual health, mood, and bone and cardiovascular health. What is DHEA and what does it really do?

Mickie Cathers

Colds and flu often result in chest congestion that can persist long after other symptoms have disappeared. An expectorant like guaifenesin can help thin mucus and phlegm and make it easier to cough up.

Mary Warner

Updates from FDA

A randomized crossover trial published in the October 2023 issue of JAMA Internal Medicine demonstrated that inappropriately sized BP cuffs significantly affected BP measurement accuracy.

Clarissa Chan, PharmD